Dr. Surabhi Amar, MD

Dr. Amar practices at Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health.

Dr. Amar's NPI, 1083698955, was assigned on December 2, 2005. Dr. Amar holds Arizona license 38050.

Dr. Amar's primary practice is Valleywise Health Medical Center, at 2601 East Roosevelt Street, Phoenix, AZ 85008 in Maricopa County. The practice phone is (602) 344-5011.

Dr. Amar's primary practice is Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health. The medical group on file is District Medical Group. Dmand AI also links Dr. Amar to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amar practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Amar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Amar's licenses on file in 2 states: Arizona and Florida.

CMS data shows 21 Medicare services from Dr. Amar across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $1,465 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Amar in 2024. The largest group is 65 to 74, with 14 patients. 67% of them have high blood pressure, and 52% have cancer. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amar's median patient age at 56, with 67% women.

In 2024, Dr. Amar wrote 157 Medicare Part D claims for 34 patients. 61% of them were for generic drugs. CMS names the drug for 80 of them, across 4 drugs with 11 or more claims each, at $746,626 in total drug cost. In 2023, CMS named 84 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Amar for performance year 2024, reported as part of a group. Dr. Amar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Amar, published from 2008 to 2021. 2019 was the busiest year, with 3. Dr. Amar has published most often in Cureus. Dr. Amar's most frequent co-authors are Dawood B. Findakly, MD, Daniel G. Gridley, MD and Divyesh Mehta, MD.

CMS Open Payments shows 712 general payments to Dr. Amar from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,981.